Page 1 of Clinical Trials for Drug pazopanib hydrochloride, 30 Total Matches
- 1RecruitingLast Updated: February 6, 2012Condition(s): Recurrent Thyroid Cancer; Stage IVA Follicular Thyroid Cancer; Stage IVA Papillary Thyroid Cancer; Stage IVB Follicular Thyroid Cancer; Stage IVB Papillary Thyroid Cancer; Stage IVC Follicular Thyroid Cancer; Stage IVC Papillary Thyroid Cancer
- 2SuspendedLast Updated: July 8, 2011Condition(s): Head and Neck Cancer
- 3Not yet recruitingLast Updated: July 23, 2011Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
- 4RecruitingLast Updated: November 22, 2011Condition(s): Pancreatic Alpha Cell Carcinoma; Pancreatic Beta Islet Cell Carcinoma; Pancreatic Delta Cell Carcinoma; Pancreatic G-cell Carcinoma; Recurrent Islet Cell Carcinoma
- 5RecruitingLast Updated: February 8, 2012Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
- 6RecruitingLast Updated: April 2, 2011Condition(s): Brain and Central Nervous System Tumors; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
- 7Not yet recruitingLast Updated: October 4, 2011Condition(s): Adult Alveolar Soft-part Sarcoma; Adult Angiosarcoma; Adult Desmoplastic Small Round Cell Tumor; Adult Epithelioid Hemangioendothelioma; Adult Epithelioid Sarcoma; Adult Extraskeletal Chondrosarcoma; Adult Fibrosarcoma; Adult Leiomyosarcoma; Adult Liposarcoma; Adult Malignant Fibrous Histiocytoma; Adult Malignant Hemangiopericytoma; Adult Malignant Mesenchymoma; Adult Neurofibrosarcoma; Adult Synovial Sarcoma; Dermatofibrosarcoma Protuberans; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma
- 8RecruitingLast Updated: December 9, 2010Condition(s): Lung Cancer
- 9WithdrawnLast Updated: January 30, 2009Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 10RecruitingLast Updated: August 3, 2011Condition(s): Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer
- 11TerminatedLast Updated: December 8, 2011Condition(s): Breast Cancer
- 12SuspendedLast Updated: April 6, 2011Condition(s): Breast Cancer; Lung Cancer; Colon Cancer; Pancreatic Cancer; Head and Neck Cancer; Kidney Cancer; Sarcoma; Hepatocellular Cancer
- 13RecruitingLast Updated: April 22, 2010Condition(s): Prostate Cancer
- 14RecruitingLast Updated: November 24, 2011Condition(s): Head and Neck Cancer
- 15Not yet recruitingLast Updated: February 2, 2012Condition(s): Renal Cell Carcinoma; Clear-cell Metastatic Renal Cell Carcinoma
- 16RecruitingLast Updated: November 9, 2011Condition(s): Clear Cell Renal Cell Carcinoma; Stage I Renal Cell Cancer; Stage II Renal Cell Cancer; Stage III Renal Cell Cancer
- 17RecruitingLast Updated: January 4, 2012Condition(s): Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer
- 18SuspendedLast Updated: January 20, 2012Condition(s): Sarcoma
- 19RecruitingLast Updated: July 26, 2011Condition(s): Lung Cancer
- 20RecruitingLast Updated: October 30, 2010Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+pazopanib+hydrochloride
